Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Annexin A9 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA555839
Description
Immunogen sequence: NLERIVMALL QPTAQFDAQE LRTALKASDS AVDVAIEILA TRTPPQLQEC LAVYKHNFQV EAVDDITSET SGIL Highest antigen sequence identity to the following orthologs: Mouse - 77%, Rat - 77%.
The annexins include ANXA9 coded protein, which are a family of calcium-dependent phospholipid-binding proteins. Members of the annexin family contain 4 internal repeat domains, each of which includes a type II calcium-binding site. The calcium-binding sites are required for annexins to aggregate and cooperatively bind anionic phospholipids and extracellular matrix proteins. Annexin A9 is a divergent member of the annexin protein family in which all four homologous type II calcium-binding sites in the conserved tetrad core contain amino acid substitutions that ablate their function. However, structural analysis suggests that the conserved putative ion channel formed by the tetrad core is intact.
Specifications
Annexin A9 | |
Polyclonal | |
Unconjugated | |
ANXA9 | |
1110003P15Rik; 2310069F17Rik; annexin 31; annexin A9; Annexin XXXI; annexin-31; Annexin-9; ANX31; Anxa9; Pemphaxin | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
8416 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.5 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
O76027 | |
ANXA9 | |
Recombinant protein corresponding to Human Annexin A9. Recombinant protein control fragment (Product #RP-94286). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction